Insys Therapeutics Inc (INSY)

10.83
NASDAQ : Health Care
Prev Close 10.83
Day Low/High 0.00 / 0.00
52 Wk Low/High 8.70 / 23.20
Avg Volume 877.30K
Exchange NASDAQ
Shares Outstanding 71.77M
Market Cap 739.23M
EPS 0.80
P/E Ratio 33.23
Div & Yield N.A. (N.A)

Latest News

Insys Therapeutics Enters Oversold Territory (INSY)

Insys Therapeutics Enters Oversold Territory (INSY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

The Worst Biopharma CEOs of 2016 Are ...

The Worst Biopharma CEOs of 2016 Are ...

There was plenty of shame to spread around, but Theranos CEO Elizabeth Holmes' loathsome mix of arrogance, incompetence and duplicity makes her the Worst CEO of 2016.

INVESTOR ALERT: Investigation Of Insys Therapeutics Announced By Holzer & Holzer

INVESTOR ALERT: Investigation Of Insys Therapeutics Announced By Holzer & Holzer

On December 8, 2016, six former executives of Insys Therapeutics, Inc.

Canadian Marijuana Market More Mature, Outperforms U.S. Market

Canadian Marijuana Market More Mature, Outperforms U.S. Market

The Canadian marijuana market is poised for growth as the number of registered patients continues grows and as licensed producers find innovative ways to create value for its shareholders.

4 Stocks You Can Buy to Profit From the Rising Use of Medical Marijuana

4 Stocks You Can Buy to Profit From the Rising Use of Medical Marijuana

GW Pharmaceuticals has developed cannabis-based therapies for treating epilepsy and multiple sclerosis.

'Mad Money' Lightning Round: American Electric Power, Amgen, Dow Chemical

'Mad Money' Lightning Round: American Electric Power, Amgen, Dow Chemical

Jim Cramer finds reasons to like AEP, AMGN, DOW and HEI.

Jim Cramer's 'Mad Money' Recap: We've Been Afraid of Higher Rates for Years

Jim Cramer's 'Mad Money' Recap: We've Been Afraid of Higher Rates for Years

This rally isn't just about Trump, Cramer says. He thinks investors are cheering the economic outlook.

Commit To Buy Insys Therapeutics At $9, Earn 22.4% Annualized Using Options

Commit To Buy Insys Therapeutics At $9, Earn 22.4% Annualized Using Options

Investors eyeing a purchase of Insys Therapeutics Inc stock, but tentative about paying the going market price of $12.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $9 strike, which has a bid at the time of this writing of 95 cents.

Three Pot Stocks to Watch for 2017

Three Pot Stocks to Watch for 2017

Donald Trump was not the only big winner on Election Day. The cannabis industry got a spark as well.

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

President-elect Trump's vague healthcare policy has put the $3 trillion industry on edge.

Even in a Trump Presidency, Marijuana Is a Good Investment

Even in a Trump Presidency, Marijuana Is a Good Investment

The U.S. president elect has said in the past that he favors the legalization of marijuana, and he is unlikely to change his stance significantly.

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.

'Mad Money' Lightning Round: Yum! Brands Split is a 'Great Idea'

'Mad Money' Lightning Round: Yum! Brands Split is a 'Great Idea'

Jim Cramer likes YUM; says STZ is more appetizing than MNST

Jim Cramer's 'Mad Money' Recap: Don't Surrender to the Index Funds

Jim Cramer's 'Mad Money' Recap: Don't Surrender to the Index Funds

Index funds are great, Jim Cramer says, but he encourages investors to do some smart stock picking.

Relative Strength Alert For Insys Therapeutics

Relative Strength Alert For Insys Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.